Dr. Hoda Z Pourhassan, MD

Claim this profile
Studies Myelodysplastic Syndrome
Studies Acute Myeloid Leukemia
1 reported clinical trial
2 drugs studied

Area of expertise

1Myelodysplastic Syndrome
Hoda Z Pourhassan, MD has run 1 trial for Myelodysplastic Syndrome. Some of their research focus areas include:
MRD positive
CD123 positive
2Acute Myeloid Leukemia
Hoda Z Pourhassan, MD has run 1 trial for Acute Myeloid Leukemia. Some of their research focus areas include:
MRD positive
CD123 positive

Clinical Trials Hoda Z Pourhassan, MD is currently running

Image of trial facility.

Tagraxofusp + Azacitidine

for AML and MDS

This phase Ib trial tests the safety, side effects, best dose and effectiveness of tagraxofusp in combination with azacitidine as maintenance therapy in treating patients with CD123 positive acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) after a donor (allogeneic) hematopoietic cell transplant. An allogeneic hematopoietic cell transplant (HCT) is a type of transplant where the cancer patient receives cells from another person. Maintenance therapy is given after the transplant to prevent the cancer from coming back. Tagraxofusp is a drug that targets cells that have CD123 on their surface in order to kill the cancer cells to help prevent the cancer from coming back. Azacitidine is in a class of medications called demethylation agents. It works by helping the bone marrow to produce normal blood cells and by killing abnormal cells. Giving tagraxofusp in combination with azacitidine may be safe, tolerable and/or effective maintenance therapy in patients with CD123 positive AML and MDS after an allogeneic HCT.
Recruiting1 award Phase 110 criteria

More about Hoda Z Pourhassan, MD

Clinical Trial Related1 year of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical Trial
Treatments Hoda Z Pourhassan, MD has experience with
  • Azacitidine
  • Tagraxofusp
Breakdown of trials Hoda Z Pourhassan, MD has run
Myelodysplastic Syndrome
Acute Myeloid Leukemia

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Hoda Z Pourhassan, MD specialize in?
Hoda Z Pourhassan, MD focuses on Myelodysplastic Syndrome and Acute Myeloid Leukemia. In particular, much of their work with Myelodysplastic Syndrome has involved MRD positive patients, or patients who are CD123 positive.
Is Hoda Z Pourhassan, MD currently recruiting for clinical trials?
Yes, Hoda Z Pourhassan, MD is currently recruiting for 1 clinical trial in the USA. If you're interested in participating, you should apply.
Are there any treatments that Hoda Z Pourhassan, MD has studied deeply?
Yes, Hoda Z Pourhassan, MD has studied treatments such as Azacitidine, Tagraxofusp.
What is the best way to schedule an appointment with Hoda Z Pourhassan, MD?
Apply for one of the trials that Hoda Z Pourhassan, MD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top